midodrine has been researched along with chronic COVID syndrome in 1 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbate, G | 1 |
| De Iulio, B | 1 |
| Thomas, G | 1 |
| Priday, A | 1 |
| Biondi-Zoccai, G | 1 |
| Markley, R | 1 |
| Abbate, A | 1 |
1 review available for midodrine and chronic COVID syndrome
| Article | Year |
|---|---|
Postural Orthostatic Tachycardia Syndrome After COVID-19: A Systematic Review of Therapeutic Interventions.
Topics: Adrenergic beta-Antagonists; Adult; COVID-19; Female; Heart Rate; Humans; Male; Middle Aged; Midodri | 2023 |